About Ntouch Research
Ntouch Research is a Healthcare company based in Raleigh (United States) founded in 1997, and was acquired by Accelovance in February 2005. Full service CRO. Ntouch Research has raised $8 million across 2 funding rounds from investors including Canaan, Accelovance and Intersouth Partners. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its competitors include Celgene, Syneos Health and Medelis WCCT Global; 2 of its 3 listed competitors have raised funding.
Company details
Ntouch Research was established in 1997 in Raleigh, United States, as a full-service contract research organization in the clinical trials sector. Complete management services are provided for Phase I through post-approval Phase IV studies, encompassing site management, monitoring, data management, biostatistics, health economics, and medical and regulatory affairs. All facilities are maintained in compliance with ICH and GCP standards.
- Headquarters Raleigh, United States
- Stage Acquired
- SectorsHealthcare
- Website ntouchresearch.com
- Social LinkedIn
- Acquired by Accelovance (Feb 2005)
- Total Equity Funding$8M (USD)
in 2 rounds
- Latest Funding Round$8M (USD), Private Equity Round
Feb 2000
- InvestorsCanaan
& 3 more
- Acquired byAccelovance
(Feb 2005)
Funding Insights of Ntouch Research
Ntouch Research has successfully raised a total of $8M across 2 strategic funding rounds. The most recent funding activity was a Private Equity Round of $8 million completed in February 2000. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $8M
- Total Rounds 2
- Last Round Private Equity Round — $8M
- First Round $1M
(Jun 1998)
- Investors Count 3
All 2 funding rounds of Ntouch Research with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2000 | $8M | Private Equity Round | – | – | |
| Jun 1998 | $1M | Unspecified | – | – |
4 investors in total: 4 institutional.
Investors in Ntouch Research
Ntouch Research has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Canaan, Accelovance and Intersouth Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Canaan is recognized as an early-stage venture capital firm. | 1987 | canaan.com | San Francisco, United States | |
Early-stage life sciences and tech focused VC firm funding companies in the US | intersouth.com | Durham, United States | ||
Investment in emerging and growth-stage MedTech companies is facilitated. | bioventuresinvestors.com | Marlborough, United States | ||
CRO specializing in Phase I-IV programs of Vaccines, Early Phase Oncology, and General medicine | 2005 | accelovance.com | Rockville, United States |
Investor details for Ntouch Research
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Ntouch Research
4 dated milestones of Ntouch Research across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Ntouch Research is founded.
- Funding First funding round of $1.0M.
- Funding Latest funding round, Private Equity Round, of $8.0M.
- Exit Acquired by Accelovance.
Competitors of Ntouch Research
Ntouch Research has 3 listed competitors in our database, 2 of them funded. They include Celgene, Syneos Health and Medelis WCCT Global.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| celgene.com | 1986 | Summit, United States | $45M | 4,891 | Therapies for cancer and inflammatory diseases are developed. | |
| syneoshealth.com | 1984 | Raleigh, United States | 29,395 | CRO clinical development services are provided by Syneos Health. | ||
| wcct.com | 1998 | Cypress, United States | $17M | 229 | Full-service CRO expertise in influenza and oncology research is offered. |
Detailed competitors of Ntouch Research
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Ntouch Research (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ntouch Research
Complete news archive for Ntouch Research
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ntouch Research
Ntouch Research was founded in 1997 and raised its 1st funding round 1 year after it was founded.
Ntouch Research is headquartered in Raleigh, United States. It is registered at Raleigh, North Carolina, United States.
Ntouch Research is a funded company, having raised a total of $8M across 2 funding rounds to date. The company's 1st funding round was a Unspecified of $1M, raised on Jun 1998.
Ntouch Research was established in 1997 in Raleigh, United States, as a full-service contract research organization in the clinical trials sector. Complete management services are provided for Phase I through post-approval Phase IV studies, encompassing site management, monitoring, data management, biostatistics, health economics, and medical and regulatory affairs. All facilities are maintained in compliance with ICH and GCP standards.
Ntouch Research's top competitors include Syneos Health, Medelis WCCT Global and Celgene.
Ntouch Research has 4 investors. Key investors include Canaan, Accelovance, Intersouth Partners, and BioVentures MedTech Funds.
Yes. Ntouch Research was acquired by Accelovance in February 2005.